Danoprevir, also known as ITMN-191 or Selleck HCV Protease inhibitor (CAS: 850876-88-9), is an antiviral medication that is used to treat hepatitis C virus (HCV) infections. This product works by inhibiting the HCV protease enzyme, which is necessary for the virus to replicate.
Chemical name: N-[(1R)-3-methyl-2-(2-oxo-1,3-dioxolan-4-yl)butyl]-6-(pyridin-3-ylmethyl)-5,8-dioxo-5,8-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide
Molecular formula: C29H30N8O6
Formula weight: 582.61 g/mol
CAS No: 850876-88-9
Top ten keywords from Google and Synonyms:
Synonyms: ITMN-191, Selleck HCV Protease inhibitor, N-[(1R)-3-methyl-2-(2-oxo-1,3-dioxolan-4-yl)butyl]-6-(pyridin-3-ylmethyl)-5,8-dioxo-5,8-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide
Health benefits of Danoprevir:
The primary health benefit of Danoprevir is its ability to inhibit the HCV protease enzyme, which is necessary for the virus to replicate. By doing so, this medication can help prevent the progression of liver disease and improve outcomes for patients with HCV.
Potential effects of Danoprevir:
Danoprevir works by inhibiting the HCV protease enzyme, which is necessary for the virus to replicate. In clinical trials, this medication has demonstrated significant antiviral activity, including rapid reductions in viral load and sustained virologic response rates. Additionally, Danoprevir may have the potential to be used in combination with other direct-acting antiviral medications for interferon-free therapy.
Product mechanism:
Danoprevir works by inhibiting the HCV protease enzyme, which is necessary for the virus to replicate. By doing so, this medication can help prevent the progression of liver disease and improve outcomes for patients with HCV. Additionally, Danoprevir may have the potential to be used in combination with other direct-acting antiviral medications for interferon-free therapy.
Safety:
Danoprevir is generally considered safe when taken as directed by a healthcare provider. However, like any medication, it does carry some risks and potential side effects. Before taking this medication, patients should discuss their medical history and any current medications with their healthcare provider to ensure that it is safe for them to take.
Side effects of Danoprevir:
Common side effects of Danoprevir include fatigue, headache, and gastrointestinal symptoms such as nausea and diarrhea. More serious side effects are rare, but may include allergic reactions, liver damage, and changes in blood cell counts. Patients who experience any of these symptoms while taking this medication should contact their healthcare provider immediately.
Dosing information:
The recommended dose of Danoprevir varies depending on the patient's medical history and condition. It is important for patients to follow their healthcare provider's instructions regarding dosing and administration of this medication.
Conclusion:
Danoprevir is an antiviral medication that is used to treat hepatitis C virus (HCV) infections. By inhibiting the HCV protease enzyme, this medication can help prevent the progression of liver disease and improve outcomes for patients with HCV. While generally considered safe, this medication does carry some risks and potential side effects, so patients should discuss their medical history and any current medications with their healthcare provider before taking it. Overall, Danoprevir is a promising medication that may hold significant potential for the treatment of HCV
